BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27482839)

  • 1. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.
    Liang G; Zhu Y; Jing A; Wang J; Hu F; Feng W; Xiao Z; Chen B
    Gene Ther; 2016 Dec; 23(12):829-838. PubMed ID: 27482839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
    Wang S; Zhang J; Wang Y; Chen M
    Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.
    Ibrahim AF; Weirauch U; Thomas M; Grünweller A; Hartmann RK; Aigner A
    Cancer Res; 2011 Aug; 71(15):5214-24. PubMed ID: 21690566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
    J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy.
    Zheng B; Chen L; Pan CC; Wang JZ; Lu GR; Yang SX; Xue ZX; Wang FY; Xu CL
    Nanomedicine (Lond); 2018 Apr; 13(7):769-785. PubMed ID: 29460671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer.
    Wang TY; Choe JW; Pu K; Devulapally R; Bachawal S; Machtaler S; Chowdhury SM; Luong R; Tian L; Khuri-Yakub B; Rao J; Paulmurugan R; Willmann JK
    J Control Release; 2015 Apr; 203():99-108. PubMed ID: 25687306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
    Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
    Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy and Photothermal Therapy of Layer-by-Layer Assembled AuNCs /PEI/miRNA/ HA Nanocomplexes.
    Yan LJ; Guo XH; Wang WP; Hu YR; Duan SF; Liu Y; Sun Z; Huang SN; Li HL
    Curr Cancer Drug Targets; 2019; 19(4):330-337. PubMed ID: 30332960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel type of self-assembled nanoparticles as targeted gene carriers: an application for plasmid DNA and antimicroRNA oligonucleotide delivery.
    Zhu Y; Liang G; Sun B; Tian T; Hu F; Xiao Z
    Int J Nanomedicine; 2016; 11():399-410. PubMed ID: 26869785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
    Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
    Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy.
    Gao S; Tian H; Guo Y; Li Y; Guo Z; Zhu X; Chen X
    Acta Biomater; 2015 Oct; 25():184-93. PubMed ID: 26169933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
    Pai Kasturi S; Qin H; Thomson KS; El-Bereir S; Cha SC; Neelapu S; Kwak LW; Roy K
    J Control Release; 2006 Jul; 113(3):261-70. PubMed ID: 16793161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pigment epithelial-derived factor gene loaded in PLGA nanoparticles for therapy of colon carcinoma.
    Cui FY; Song XR; Li ZY; Li SZ; Mu B; Mao YQ; Wei YQ; Yang L
    Oncol Rep; 2010 Sep; 24(3):661-8. PubMed ID: 20664971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
    Katas H; Cevher E; Alpar HO
    Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma.
    Cai C; Xie Y; Wu L; Chen X; Liu H; Zhou Y; Zou H; Liu D; Zhao Y; Kong X; Liu P
    Sci Rep; 2017 Apr; 7():46250. PubMed ID: 28387375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
    Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
    Xia Y; Guo M; Xu T; Li Y; Wang C; Lin Z; Zhao M; Zhu B
    Int J Nanomedicine; 2018; 13():1539-1552. PubMed ID: 29588583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.
    Song C; Noh YW; Lim YT
    Int J Nanomedicine; 2016; 11():3753-64. PubMed ID: 27540289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated composite nanoparticles of PLGA and polyethylenimine for safe and efficient delivery of pDNA to lungs.
    Kolte A; Patil S; Lesimple P; Hanrahan JW; Misra A
    Int J Pharm; 2017 May; 524(1-2):382-396. PubMed ID: 28391040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.